In Staging Creolization, Emily Sahakian examines seven plays by Ina Césaire, Maryse Condé, Gerty Dambury, and Simone Schwarz-Bart that premiered in the French Caribbean or in France in the 1980s and 1990s and soon thereafter traveled to the United States. Sahakian argues that these late-twentieth-century plays by French Caribbean women writers dramatize and enact creolization—the process of cultural transformation through mixing and conflict that occurred in the context of the legacies of slavery and colonialism. Sahakian here theorizes creolization as a performance-based process, dramatized by French Caribbean women’s plays and enacted through their international production and reception histories. The author contends that the syncretism of the plays is not a static, fixed creole aesthetics but rather a dynamic process of creolization in motion, informed by history and based in the African-derived principle that performance is a space of creativity and transformation that connects past, present, and future.
In Staging Creolization, Emily Sahakian examines seven plays by Ina Césaire, Maryse Condé, Gerty Dambury, and Simone Schwarz-Bart that premiered in the French Caribbean or in France in the 1980s and 1990s and soon thereafter traveled to the United States. Sahakian argues that these late-twentieth-century plays by French Caribbean women writers dramatize and enact creolization—the process of cultural transformation through mixing and conflict that occurred in the context of the legacies of slavery and colonialism. Sahakian here theorizes creolization as a performance-based process, dramatized by French Caribbean women’s plays and enacted through their international production and reception histories. The author contends that the syncretism of the plays is not a static, fixed creole aesthetics but rather a dynamic process of creolization in motion, informed by history and based in the African-derived principle that performance is a space of creativity and transformation that connects past, present, and future.
Foreword by Robert Hauptman As discussions about the roles played by information in economic, political, and social arenas continue to evolve, the need for an intellectual primer on information ethics that also functions as a solid working casebook for LIS students and professionals has never been more urgent. This text, written by a stellar group of ethics scholars and contributors from around the globe, expertly fills that need. Organized into twelve chapters, making it ideal for use by instructors, this volume from editors Burgess and Knox thoroughly covers principles and concepts in information ethics, as well as the history of ethics in the information professions; examines human rights, information access, privacy, discourse, intellectual property, censorship, data and cybersecurity ethics, intercultural information ethics, and global digital citizenship and responsibility; synthesizes the philosophical underpinnings of these key subjects with abundant primary source material to provide historical context along with timely and relevant case studies; features contributions from John M. Budd, Paul T. Jaeger, Rachel Fischer, Margaret Zimmerman, Kathrine A. Henderson, Peter Darch, Michael Zimmer, and Masooda Bashir, among others; and offers a special concluding chapter by Amelia Gibson that explores emerging issues in information ethics, including discussions ranging from the ethics of social media and social movements to AI decision making. This important survey will be a key text for LIS students and an essential reference work for practitioners.
The principal purpose of this book is to tell the story of a medicine's journey through the regulatory system in the UK, from defining what counts as a medicine, through clinical trials, licensing, pharmacovigilance, marketing and funding. The question of global access to medicines is addressed because of its political importance, and because it offers a particularly stark illustration of the consequences of classifying medicines as a private rather than a public good. Two further specific challenges to the future of medicine's regulation are examined separately: first, pharmacogenetics, or the genetic targeting of medicines to subgroups of patients, and second, the possibility of using medicines to enhance well-being or performance, rather than treat disease. Throughout, the emphasis is on the role of regulation in shaping and influencing the operation of the medicines industry, an issue that is of central importance to the promotion of public health and the fair and equitable distribution of healthcare resources.
A collection of puzzles, games and other activities based on facts about Michigan geography, history, culture, recreation and attractions"--Title page verso.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.